A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalized treatment can slow or even ...
Please provide your email address to receive an email when new articles are posted on . The model predicted a 12.6% average risk for recurrent disease activity among DMT discontinuers. The model’s AUC ...
In the human brain, neurofilament light chain (NfL, shown in brown) is seen in brain cells and the neural wires that connect them. UCSF researchers found NfL in the bloodstream of patients who would ...
Now, by analyzing thousands of proteins found in the blood, scientists at UC San Francisco have created the clearest picture yet of when the disease attacks the myelin sheath that covers the nerve ...
A new study published in Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for ...
A novel program provided evidence that addressing long-known disparities in high-efficacy multiple sclerosis (MS) treatment for minority populations is a solvable problem. The program, presented by ...
Multiple sclerosis (MS) is an autoimmune condition in which the protective insulation surrounding neurons in the brain and spinal cord is erroneously attacked. This can cause a wide variety of serious ...
The San Diego Padres could be on the verge of losing two coaches amid the coaching carousel getting underway shortly. The Padres lost in devastating fashion, dropping two out of three games in the ...
Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...
Women with relapsing-remitting multiple sclerosis (MS), particularly after menopause, experienced a higher risk of relapse-independent worsening, whereas men showed a greater worsening of disability ...
HENRICO COUNTY, Va. — Walking into Mimi Murdock's Henrico home is a lot like stepping into a painting. "My house, everything's fluid, you know, it's just going to change," Murdock said. "I'm a visual ...
EMERYVILLE, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results